Description
Tirzepatide is supplied as lyophilized material for non-clinical laboratory research by qualified facilities and trained personnel.
Product details
• Net content: 10 MG per vial
• Format: Lyophilized material
• Container: 3 mL glass vial
• Lot/batch: Recorded on product label where available
Intended use
• Non-clinical laboratory research
• Analytical reference and assay development
• Use only in accordance with institutional SOPs and applicable regulatory requirements
• Not for human or animal consumption
• Not for clinical, therapeutic, or diagnostic use
Certificate of Analysis (COA)
For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for Tirzepatide 10MG.
HEALTH CANADA WARNING
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. They may contain high-risk ingredients, such as prescription or controlled drugs, and additives or contaminants that may or may not be listed on the label. The level of active ingredients could be higher or lower than claimed and these ingredients could interact with other medications and foods. Prescription drugs should only be used under the care of a licensed health care professional because they are intended to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription.
